2-(4-[4-(2-methoxyphenyl)piperidin-1-yl]-2-phenylquinazolin-6-yl-methylamino)ethanol

ID: ALA4464635

Chembl Id: CHEMBL4464635

PubChem CID: 118610246

Max Phase: Preclinical

Molecular Formula: C29H32N4O2

Molecular Weight: 468.60

Molecule Type: Unknown

Names and Identifiers

Canonical SMILES:  COc1ccccc1C1CCN(c2nc(-c3ccccc3)nc3ccc(N(C)CCO)cc23)CC1

Standard InChI:  InChI=1S/C29H32N4O2/c1-32(18-19-34)23-12-13-26-25(20-23)29(31-28(30-26)22-8-4-3-5-9-22)33-16-14-21(15-17-33)24-10-6-7-11-27(24)35-2/h3-13,20-21,34H,14-19H2,1-2H3

Standard InChI Key:  BODOCBQUMDLJMW-UHFFFAOYSA-N

Alternative Forms

1. Parent:

   

   ALA4464635

   US10118902, Example 144

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Unknown

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 468.60

Molecular Weight (Monoisotopic): 468.2525

AlogP: 5.12

#Rotatable Bonds: 7

Polar Surface Area: 61.72

Molecular Species: NEUTRAL

HBA: 6

HBD: 1

#RO5 Violations: 1

HBA (Lipinski): 6

HBD (Lipinski): 1

#RO5 Violations (Lipinski): 1

CX Acidic pKa: ┄

CX Basic pKa: 5.27

CX LogP: 6.19

CX LogD: 6.19

Aromatic Rings: 4

Heavy Atoms: 35

QED Weighted: 0.41

Np Likeness Score: -1.24

References

1. Pinkerton AB, Peddibhotla S, Yamamoto F, Slosky LM, Bai Y, Maloney P, Hershberger P, Hedrick MP, Falter B, Ardecky RJ, Smith LH, Chung TDY, Jackson MR, Caron MG, Barak LS..  (2019)  Discovery of β-Arrestin Biased, Orally Bioavailable, and CNS Penetrant Neurotensin Receptor 1 (NTR1) Allosteric Modulators.,  62  (17): [PMID:31390201] [10.1021/acs.jmedchem.9b00340]

Source

Source(1):

• Scientific Literature